登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002024 证券简称：ST易购 公告编号：2025-031 苏宁易购集团股份有限公司 2025年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、召开时间： （1）现场会议召开时间：2025年6月30日（星期一）下午14:00。 （2）网络投票时间：2025年6月30日。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为2025年6月30日上午9:15－9:25，9:30－ 11:30，下午13:00－15:00。通过深圳证券交易所互联网投票系统投票的具体时间为2025年6月30日上午 9:15至下午15:00期间的任意时间。 2、现场会议召开地点：南京市玄武区苏宁大道1号苏宁易购总部办公楼会议中心。 3、会议召集人：公司董事会。 4、会议方式：本次股东大会采取现场投票、网络投票相结合的方式召开。 1、本次股东大会无否决提案的情形。 提案1：《关于债务和 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码：000629 股票简称：钒钛股份 公告编号：2025-54 攀钢集团钒钛资源股份有限公司 第九届董事会第二十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 攀钢集团钒钛资源股份有限公司（以下简称"公司"）于2025年6月17日以专人递送、电子邮件等方式发 出关于召开公司第九届董事会第二十五次会议的通知和议案资料，会议于2025年6月27日16:00在公司 701会议室召开，本次会议应出席董事9名，实际出席董事9名。会议由董事长马朝辉先生主持，公司监 事及高级管理人员列席会议。本次会议的召开符合《中华人民共和国公司法》及其他有关法律法规和本 公司章程的规定。经与会董事审慎讨论，本次会议形成如下决议： 一、审议并通过了《关于聘任副总经理的议案》，决定聘任徐聪先生为公司副总经理，任期与本届董事 会一致。 徐聪先生简历附后。 三、审议并通过了《关于修订〈公司章程〉及有关制度的议案》,同意将修订后的《公司章程》《公司 股东会议事规则》和《公司董事会议事规则》提交公司2025年第三次临时股东大会 ...

Core Viewpoint - A securities class action lawsuit has been filed against Apple Inc. for allegedly making false and misleading statements regarding the integration of advanced AI-based Siri features into its devices, which may impact iPhone 16 sales and the company's financial prospects [1][2]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Northern District of California on behalf of investors who purchased Apple securities between June 10, 2024, and June 9, 2025 [1]. - The lead plaintiff deadline for the lawsuit is August 19, 2025 [1][3]. - The complaint alleges that Apple misrepresented the timeline for integrating advanced AI features, leading to overstated business and financial prospects [2]. Group 2: Allegations Against Apple - The complaint claims that Apple failed to disclose that the advanced AI-based Siri features were unlikely to be available for the iPhone 16 [2]. - It is alleged that the absence of these features would negatively affect iPhone 16 sales [2]. - As a result of these issues, Apple's public statements were deemed materially false and misleading throughout the class period [2]. Group 3: Lead Plaintiff Process - Investors can seek to be appointed as a lead plaintiff representative of the class by the deadline or may choose to remain absent [3]. - The lead plaintiff is typically the investor or group of investors with the largest financial interest in the case [3]. - The lead plaintiff will select counsel to represent the class, and participation as a lead plaintiff does not affect the ability to share in any recovery [3].

金十数据7月1日讯，截至2:30收盘，沪金主力合约收涨0.54%，报769元/克，沪银主力合约收涨0.10%， 报8722元/千克，SC原油主力合约收涨0.30%，报498元/桶。 夜盘主力合约收盘 ...

美联邦政府就移民政策起诉洛杉矶市 智通财经7月1日电，据央视新闻报道，美国特朗普政府当地时间6月30日就移民政策问题对加利福尼亚 州洛杉矶市提起诉讼。这起由美国司法部提起的诉讼称，洛杉矶的法律和政策阻碍了联邦移民法的执 行。美国司法部长在一份声明中称，像洛杉矶这样藐视联邦法律、优先处理非法移民而非美国公民的司 法管辖区，正在破坏各级执法。6月初，美国移民与海关执法局等联邦机构在加州洛杉矶县多地展开针 对非法移民的执法行动，与当地居民连续发生冲突。6月7日，特朗普签署总统备忘录，在加州州长纽森 没有请求支援的情况下，下令国防部调动加州国民警卫队人员进驻洛杉矶地区。此举遭到民主党执政的 洛杉矶地方政府和加州政府强烈反对。 ...

Core Viewpoint - As of June 30, 2025, Zhejiang Haizheng Biomaterials Co., Ltd. (海正生材) reported a closing price of 12.66 yuan, reflecting a decrease of 0.24% with a turnover rate of 5.89% and a trading volume of 69,300 shares, amounting to a transaction value of 87.1 million yuan [1]. Trading Information Summary - On June 30, 2025, the fund flow for Haizheng Biomaterials was as follows: - Net outflow of main funds was 14.64 million yuan, accounting for 16.81% of the total transaction value - Net inflow of retail funds was 11.67 million yuan, representing 13.39% of the total transaction value - Net inflow of speculative funds was 2.97 million yuan, making up 3.41% of the total transaction value [2][4]. Company Announcement Summary - Zhejiang Haizheng Biomaterials announced a shareholder reduction plan: - As of the announcement date, Sinopec Capital held 13,659,494 shares, representing 6.74% of the total share capital - Sinopec Capital plans to reduce up to 3,525,600 shares within three months through block trading, which is no more than 1.74% of the total share capital, with the reduction price determined by market conditions - In the past 12 months, Sinopec Capital has reduced 2,026,780 shares, accounting for 1% of the total share capital, with a reduction price range of 10.17 to 12.02 yuan per share - Sinopec Capital has committed not to transfer or manage the shares held prior to the public offering for 12 months post-listing or three years after completing the business registration [2][4].

上海黄金交易所黄金T+D 6月30日（周一）晚盘收盘上涨0.44%报763.98元/克； 上海黄金交易所白银T+D 6月30日（周一）晚盘收盘上涨0.01%报8698.0元/千克。 黄金延期 白银延期 ...

Core Insights - Tevogen Bio Holdings Inc. emphasizes the significance of AI in drug discovery and has made a substantial investment in its new corporate headquarters [1][2] - The new facility will enhance collaboration among cross-functional teams and support the development of Tevogen's AI platforms [2][3] - The CEO's personal investment reflects strong leadership conviction in the company's mission and long-term vision for affordable cell therapies [3] Company Developments - The CEO, Ryan Saadi, M.D., M.P.H., contributed $500,000 for the build-out and first-year operating costs of the new headquarters in Warren, New Jersey [1] - The new facility more than doubles the previous operational footprint and centralizes various teams, including research and regulatory affairs [2] - The dedicated collaboration spaces are designed to facilitate the work of data scientists and engineers on Tevogen's proprietary AI platforms, PredicTcell™ and AdapTcell™ [2] Financial Outlook - The CFO, Kirti Desai, highlighted that the CEO's investment underscores the leadership's commitment to capital discipline while enabling efficient scaling [3]

NEW YORK, June 30, 2025 /PRNewswire/ --Why: New York, N.Y., June 30, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline.So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket ...

PHILADELPHIA, June 30, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) on behalf of purchasers of Compass securities between May 1, 2024 through May 7, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Compass securities during the Class Period may, no later than JULY 8, 2025, seek to be appointed as a lead plaintiff rep ...